Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation

This publication has 45 references indexed in Scilit:

• Human CD4+CD25+ Regulatory, Contact-dependent T Cells Induce Interleukin 10–producing, Contact-independent Type 1-like Regulatory T Cells
  The Journal of Experimental Medicine, 2002
• CD4+CD25+ Regulatory T Cells Can Mediate Suppressor Function in the Absence of Transforming Growth Factor β1 Production and Responsiveness
  The Journal of Experimental Medicine, 2002
• Infectious Tolerance
  The Journal of Experimental Medicine, 2002
• CD38+ CD45RBlow CD4+ T cells: a population of T cells with immune regulatory activitiesin vitro
  European Journal of Immunology, 1998
• Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation--A Prospective, Randomized, Double-Blind Study
  The Journal of Infectious Diseases, 1995
• Impairment of leukaemia-free survival by addition of interleukin-2-receptor antibody to standard graft-versus-host prophylaxis
  The Lancet, 1995
• Immunotoxins constructed with anti‐CD25 monoclonal antibodies and deglycosylated ricin a‐chain have potent anti‐tumour effects against human hodgkin cells in vitro and solid hodgkin tumours in mice
  International Journal of Cancer, 1991
• A PHASE I-II STUDY EVALUATING THE MURINE ANTI-IL-2 RECEPTOR ANTIBODY 2A3 FOR TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE
  Transplantation, 1990
• Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences.
  The Journal of Experimental Medicine, 1986
• Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
  New England Journal of Medicine, 1986